These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16689780)

  • 1. A rapid genotyping method for the vitamin K epoxide reductase complex subunit 1 (VKORC1) gene.
    Hatch E; Sconce EA; Daly AK; Kamali F
    J Thromb Haemost; 2006 May; 4(5):1158-9. PubMed ID: 16689780
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of the vitamin K epoxide reductase complex subunit 1 G-1639A and C1173T single nucleotide polymorphisms in retinal vein occlusion.
    Ortak H; Söğüt E; Demir H; Ardagil A; Benli I; Sahin S
    Clin Exp Ophthalmol; 2012; 40(7):743-8. PubMed ID: 22394334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genotyping method for VKORC1 1173C > T by Pyrosequencing technology.
    Enström C; Osman A; Lindahl TL
    Scand J Clin Lab Invest; 2008; 68(5):427-30. PubMed ID: 19172700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vitamin K epoxide reductase-oxidase complex gene polymorphism (-1639G>A) and interindividual variability in the dose-effect of vitamin K antagonists.
    Stepien E; Branicka A; Ciesla-Dul M; Undas A
    J Appl Genet; 2009; 50(4):399-403. PubMed ID: 19875892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin K epoxide reductase complex 1 gene polymorphism and warfarin dose requirement in Chinese patients].
    Jiang NX; Song J; Xu B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):652-4. PubMed ID: 17961434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid single-nucleotide polymorphism detection of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genes for the warfarin dose adjustment by the SMart-amplification process version 2.
    Aomori T; Yamamoto K; Oguchi-Katayama A; Kawai Y; Ishidao T; Mitani Y; Kogo Y; Lezhava A; Fujita Y; Obayashi K; Nakamura K; Kohnke H; Wadelius M; Ekström L; Skogastierna C; Rane A; Kurabayashi M; Murakami M; Cizdziel PE; Hayashizaki Y; Horiuchi R
    Clin Chem; 2009 Apr; 55(4):804-12. PubMed ID: 19181737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a rapid and inexpensive allele-specific amplification (ASA)-PCR genotyping assay for vitamin K antagonist pharmacogenomics.
    Spohn G; Geisen C; Luxembourg B; Sittinger K; Seifried E; Bönig H
    Mol Diagn Ther; 2011 Feb; 15(1):13-9. PubMed ID: 21469766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SYBR Green-based real-time PCR assay for detection of VKORC1 and CYP2C9 polymorphisms that modulate warfarin dose requirement.
    Huang SW; Li Q; Zhu SY; Li L; Xiong F; Jia YK; Xu XM
    Clin Chem Lab Med; 2009; 47(1):26-31. PubMed ID: 19117406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin K epoxide reductase complex subunit 1 gene polymorphism is associated with atherothrombotic complication after drug-eluting stent implantation: 2-Center prospective cohort study.
    Suh JW; Baek SH; Park JS; Kang HJ; Chae IH; Choi DJ; Park HJ; Kim PJ; Seung KB; Kim HS
    Am Heart J; 2009 May; 157(5):908-12. PubMed ID: 19376320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin K epoxide reductase (VKORC1) gene mutations in osteoporosis: A pilot study.
    Holzer G; Grasse AV; Zehetmayer S; Bencur P; Bieglmayer C; Mannhalter C
    Transl Res; 2010 Jul; 156(1):37-44. PubMed ID: 20621035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K epoxide reductase genetic polymorphism is associated with venous thromboembolism: results from the EDITH Study.
    Lacut K; Larramendy-Gozalo C; Le Gal G; Duchemin J; Mercier B; Gourhant L; Mottier D; Becquemont L; Oger E; Verstuyft C
    J Thromb Haemost; 2007 Oct; 5(10):2020-4. PubMed ID: 17883698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.
    Aquilante CL; Langaee TY; Lopez LM; Yarandi HN; Tromberg JS; Mohuczy D; Gaston KL; Waddell CD; Chirico MJ; Johnson JA
    Clin Pharmacol Ther; 2006 Apr; 79(4):291-302. PubMed ID: 16580898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphism of vitamin K epoxide reductase (VKORC1) 1173C>T in a Chinese and a Caucasian population.
    Larramendy-Gozalo C; Yang JQ; Verstuyft C; Bodin L; Dubert L; Zhang Y; Xu C; Fan L; Jaillon P; Becquemont L
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):611-3. PubMed ID: 16700826
    [No Abstract]   [Full Text] [Related]  

  • 14. [Vitamin K epoxide reductase: Fresh blood for oral anticoagulant therapies].
    Loriot MA; Beaune P
    Rev Med Interne; 2006 Dec; 27(12):979-82. PubMed ID: 17070618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K epoxide reductase (VKORC1) genetic polymorphism is associated to oral anticoagulant overdose.
    Quteineh L; Verstuyft C; Descot C; Dubert L; Robert A; Jaillon P; Becquemont L
    Thromb Haemost; 2005 Sep; 94(3):690-1. PubMed ID: 16268497
    [No Abstract]   [Full Text] [Related]  

  • 16. Exciton Primer-mediated SNP detection in SmartAmp2 reactions.
    Lezhava A; Ishidao T; Ishizu Y; Naito K; Hanami T; Katayama A; Kogo Y; Soma T; Ikeda S; Murakami K; Nogawa C; Itoh M; Mitani Y; Harbers M; Okamoto A; Hayashizaki Y
    Hum Mutat; 2010 Feb; 31(2):208-17. PubMed ID: 20052755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population.
    Veenstra DL; You JH; Rieder MJ; Farin FM; Wilkerson HW; Blough DK; Cheng G; Rettie AE
    Pharmacogenet Genomics; 2005 Oct; 15(10):687-91. PubMed ID: 16141794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K epoxide reductase complex subunit 1 (VKORC1 ) polymorphism influences the anticoagulation response subsequent to vitamin K intake: a pilot study.
    Sconce EA; Avery PJ; Wynne HA; Kamali F
    J Thromb Haemost; 2008 Jul; 6(7):1226-8. PubMed ID: 18466315
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacodynamic resistance to warfarin associated with a Val66Met substitution in vitamin K epoxide reductase complex subunit 1.
    Harrington DJ; Underwood S; Morse C; Shearer MJ; Tuddenham EG; Mumford AD
    Thromb Haemost; 2005 Jan; 93(1):23-6. PubMed ID: 15630486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistance.
    Bodin L; Horellou MH; Flaujac C; Loriot MA; Samama MM
    J Thromb Haemost; 2005 Jul; 3(7):1533-5. PubMed ID: 15978113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.